BSX Boston Scientific Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
13:49
Oct 13
Oct 13
r/stocks
Wants to add to BSX
The commenter states they want to add to their BSX position. No causal rationale or catalyst is provided beyond the stated intention to increase the holding. Main risk is unspecified.
BSX
Boston Scientific
Long
1ST
Position: Added
—
16:33
Sep 24
Sep 24
r/stocks
Strong growth, cheap valuation, insider buying
Author argues BSX is a healthy medical-device business with strong organic growth (12.3% in 2023, 16.4% in 2024, 15.8% in 2025) and Cardiovascular, about two-thirds of revenue, growing 20.8% organically in 2025. Valuation looks reasonable at ~18x trailing and ~13x forward P/E on a ~$65B market cap. Catalyst: CEO Michael Mahoney bought ~$9M of shares at ~$48.33 on August 3, plus a disclosed congressional purchase. Main stated risk: a 2026 slowdown that has pressured the share price this year.
BSX
Boston Scientific
Long
1ST
—
—
About BSX Investor Commentary
Across the available history and selected sources, Buzzberg tracks BSX (Boston Scientific) across 21 sources: 22 bullish vs 1 bearish calls from 44 authors. Historical directional balance: 28% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 74 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: u/tired_ani, crux_capital_, u/Rambok01.